Argen X SE - ADR (ARGX) Company Profile & Statistics

Argen X SE - ADR
ARGX
(Nasdaq - US)
Closed
596.69
+4.87 (+0.82%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
587.44
High
600.92
Low
583.06

About Argen X SE - ADR

CEO

Tim Van Hauwermeiren

Headquarters

laarderhoogtweg 25

amsterdam, p7 1101eb, netherlands

Auditor

Deloitte Accountants B.V.

Employees

1,148

Share Holders

Website

www.argenx.com

Industry

pharmaceuticals other

Sector

health technology

Company Overview

argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.

Argen X SE - ADR Statistics

Valuation Measures

Market Capitalization ²	35.68B
Enterprise Value	35.68B
Enterprise Value/EBITDA (ttm)	-210.17
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	8.06
Price to Sales (ttm)	18.00
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	90.46%
Operating Margin (ttm)	-2.11%
Profit Margin (ttm)	-3.71%
Return on Equity (ttm)	-1.45%
Return on Invested Capital (ttm)	-1.74%
Return on Assets (ttm)	-1.29%

Income Statement

Revenue (ttm)	1.50B
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	1.35B
EBITDA (ttm)³	-169.78M
Net Income Avi to Common (ttm)	21.30M
Diluted EPS (ttm)	-0.88

Share Statistics

Beta (5Y Monthly)	0.61
52-Week Change	21.95%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	0.00%
Float ⁴	58.34M
% Held by Insiders	2.43%
% Held by Institutions	60.32%

Balance Sheet

Total Cash (mrq)	0.00
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	N/A
Quick Ratio (mrq)	7.88%
Book Value Per Share (mrq)	N/A

Cash Flow

Operating Cash Flow Per Share (ytd)	N/A
Free Cash Flow (ytd)	0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Argen X SE - ADR

Trade With A Regulated Broker